Exosomes and Non-Coding Rnas: Exploring Their Roles in Human Myocardial Dysfunction Publisher Pubmed



Kulus M¹ ; Farzaneh M² ; Sheykhisabzehpoush M³ ; Ghaedrahmati F⁴ ; Mehravar F⁵ ; Jozkowiak M^{6, 7} ; Piotrowskakempisty H^{7, 8} ; Bukowska D⁹ ; Antosik P¹ ; Podhorskaokolow M¹⁰ ; Zabel M^{11, 12} ; Mozdziak P^{13, 14} ; Dziegiel P^{12, 15} ; Kempisty B^{1, 6, 13, 16} Show Affiliations
Source: Biomedicine and Pharmacotherapy Published:2025

Abstract

Myocardial dysfunction, characterized by impaired cardiac muscle function, arises from diverse etiologies, including coronary artery disease, myocardial infarction, cardiomyopathies, hypertension, and valvular heart disease. Recent advancements have highlighted the roles of exosomes and non-coding RNAs in the pathophysiology of myocardial dysfunction. Exosomes are small extracellular vesicles released by cardiac and other cells that facilitate intercellular communication through their molecular cargo, including ncRNAs. ncRNAs are known to play critical roles in gene regulation through diverse mechanisms, impacting oxidative stress, fibrosis, and other factors associated with myocardial dysfunction. Dysregulation of these molecules correlates with disease progression, presenting opportunities for therapeutic interventions. This review explores the mechanistic interplay between exosomes and ncRNAs, underscoring their potential as biomarkers and therapeutic agents in myocardial dysfunction. Emerging evidence supports the use of engineered exosomes and modified ncRNAs to enhance cardiac repair by targeting signaling pathways associated with fibrosis, apoptosis, and angiogenesis. Despite promising preclinical results, delivery, stability, and immunogenicity challenges remain. Further research is needed to optimize clinical translation. Understanding these intricate mechanisms may drive the development of innovative strategies for diagnosing and treating myocardial dysfunction, ultimately improving patient outcomes. © 2025 The Authors